Drug Patent Expirations in February 2016

Drug Patent Expirations for February 2016

Tradename Applicant Generic Name Patent Number Patent Expiration
ELOXATIN Sanofi Aventis Us oxaliplatin 5,716,988*PED Feb 7, 2016
JUXTAPID Aegerion lomitapide mesylate 5,712,279 Feb 21, 2016
ARNUITY ELLIPTA Glaxosmithkline fluticasone furoate 5,873,360 Feb 23, 2016
ANORO ELLIPTA Glaxosmithkline umeclidinium bromide; vilanterol trifenatate 5,873,360 Feb 23, 2016
INCRUSE ELLIPTA Glaxo Grp England umeclidinium bromide 5,873,360 Feb 23, 2016
AMBISOME Astellas amphotericin b 5,874,104 Feb 23, 2016
BREO ELLIPTA Glaxo Grp Ltd fluticasone furoate; vilanterol trifenatate 5,873,360 Feb 23, 2016
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.
Click here for reuse options!
Copyright 2016 Biotechblog

Comments are closed.

%d bloggers like this: